相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
Recombinant H1N1 HA protein
- 亚型:
Rabbit IgG
- 形态:
液体
- 保存条件:
在-20℃ to -80℃
- 克隆性:
MAb
- 适应物种:
兔
- 保质期:
12个月
- 目录编号:
86001-RM01
- 级别:
免疫学试剂
- 库存:
99
- 供应商:
北京义翘神州科技股份有限公司
- 宿主:
Rabbit
- 应用范围:
WB,ELISA
- 浓度:
WB: 1:2000-1:20000;ELISA: 1:1000-1:2000
- 靶点:
HA
- 抗体英文名:
Influenza A Virus Hemagglutinin / HA Antibody, Rabbit MAb
- 抗体名:
甲型流感 Hemagglutinin / HA 兔单抗
- 规格:
20 µL/100 µL
| 规格: | 20 µL | 产品价格: | ¥800.0 |
|---|---|---|---|
| 规格: | 100 µL | 产品价格: | ¥2500.0 |
Hemagglutinin/HA|Hemagglutinin/HA antibody|Hemagglutinin/HA抗体|Anti-Influenza 兔单抗(产品说明)
抗体种属:Influenza
抗体靶点:HA
抗体应用:WB,ELISA
抗原描述:Recombinant H1N1 HA protein
抗体宿主:Rabbit
抗体Ig类型:Rabbit IgG
抗体纯化方法:Protein A
抗体制备:This antibody was obtained from a rabbit immunized with purified, recombinant Influenza A virus H1N1 Hemagglutinin extracellular domain.
抗体特异性:H1N1 (A/California/04/2009) HA H1N1 (A/California/07/2009) HA
抗体保存:This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验1, Jang YJ, et al. Synthesis and anti-influenza virus activity of 4-oxo- or thioxo-4,5-dihydrofuro[3,4-c]pyridin-3(1H)-ones.Antiviral research, PubMed ID: 24794525
2, Zhao L, et al. New insights into the non-conserved non-coding region of the subtype-determinant HA and NA segments of influenza A viruses.Journal of virology, PubMed ID: 25056889
3, Wang J, et al. Influenza A virus Utilizes a Suboptimal Kozak Sequence to Fine-tune Virus Replication and Host Response.The Journal of general virology, PubMed ID: 25519170
4, Miyauchi K, et al. Protective neutralizing influenza antibody response in the absence of T follicular helper cells.Nature immunology, PubMed ID: 27798619
5, Wang J, et al. The dual roles of the HA segment-specific noncoding nucleotides in the extended duplex region of the influenza A virus RNA promoter.Journal of virology, PubMed ID: 27795444
6, Gao S, et al. Identification of a type-specific promoter element that differentiates between influenza A and B viruses.Journal of virology, PubMed ID: 31534045
7, Jang Y, et al. In Vitro and In Vivo Antiviral Activity of Nylidrin by Targeting the Hemagglutinin 2-Mediated Membrane Fusion of Influenza A Virus.Viruses, PubMed ID: 32466302
8, Liu X, et al. A universal dual mechanism immunotherapy for the treatment of influenza virus infections.Nature communications, PubMed ID: 33154358
9, Jang Y, et al. Antiviral activity of lambda-carrageenan against influenza viruses...Scientific reports, PubMed ID: 33436985
10, Jitobaom K, et al. Human Schlafen 11 inhibits influenza A virus production.Virus research, PubMed ID: 37356582
11, Xing M, et al. An intranasal combination vaccine induces systemic and mucosal immunity against COVID-19 and influenza.NPJ vaccines, PubMed ID: 38509167
and production of vaccine. Since influenza is caused by a zoonotic virus it is necessary to do surveillance in the reservoir species (aquatic waterfowls), intermediate hosts (quails, pigs), and in affected mammals including humans. Two of the hemagglutinin (HA
A Brief Introduction to the Avian Influenza Virus
in [1 ]). Type A influenza strains are classified by the serological subtypes of the primary viral surface proteins, the hemagglutinin (HA) and neuraminidase (NA). The HA has 16 subtypes (H1–H16) and contains neutralizing epitopes. Antibodies against the NA
The hemagglutination-inhibition (HI) assay is a classical laboratory procedure for the classification or subtyping of hemagglutinating viruses. For the avian influenza (AI) virus, the HI assay is used to identify the hemagglutinin (H) subtype
技术资料暂无技术资料 索取技术资料









